Clinical Study
Lithium Carbonate in the Treatment of Graves’ Disease with ATD-Induced Hepatic Injury or Leukopenia
Table 4
Adverse reaction of lithium treatment.
| | GD with hepatic injury | GD with leukopenia |
| Number of patients | 33 | 18 | Neurological symptoms (%) | | | Mental confusion | 0 | 0 | Seizures | 0 | 0 | Drowsiness | 0 | 0 | Dizziness | 0 | 0 | Tremor | 0 | 0 | Gastrointestinal symptoms (%) | | | Nausea | 3 (9.0) | 2 (11.1) | Vomiting | 1 (3.0) | 0 | Diarrhea | 0 | 1 (5.5) | Abdominal distention | 1 (3.0) | 0 | Constipation | 0 | 0 | Other symptoms (%) | | | Asthenia | 1 (3.0) | 0 | Malaise | 0 | 1 (5.5) | Blurred vision | 0 | 0 |
|
|
Data were expressed as percentage of the total.
|